Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank.
diet
incidence
non-alcoholic fatty liver disease
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
23 Nov 2023
23 Nov 2023
Historique:
revised:
26
10
2023
received:
06
09
2023
accepted:
05
11
2023
medline:
24
11
2023
pubmed:
24
11
2023
entrez:
24
11
2023
Statut:
aheadofprint
Résumé
This study aimed to contrast the associations of five common diet scores with severe non-alcoholic fatty liver disease (NAFLD) incidence. In total, 162 999 UK Biobank participants were included in this prospective population-based study. Five international diet scores were included: the 14-Item Mediterranean Diet Adherence Screener (MEDAS-14), the Recommended Food Score (RFS), the Healthy Diet Indicator (HDI), the Mediterranean Diet Score and the Mediterranean-DASH Intervention for Neurodegenerative Delay score. As each score has different measurements and scales, all scores were standardized and categorized into quartiles. Cox proportional hazard models adjusted for confounder factors investigated associations between the standardized quartiles and severe NAFLD incidence. Over a median follow-up of 10.2 years, 1370 participants were diagnosed with severe NAFLD. When the analyses were fully adjusted, participants in quartile 4 using the MEDAS-14 and RFS scores, as well as those in quartiles 2 and 3 using the HDI score, had a significantly lower risk of severe incident NAFLD compared with those in quartile 1. The lowest risk was observed in quartile 4 for the MEDAS-14 score [hazard ratio (HR): 0.76 (95% confidence interval (CI): 0.62-0.94)] and the RFS score [HR: 0.82 (95% CI: 0.69-0.96)] and as well as in quartile 2 in the HDI score [HR: 0.80 (95% CI: 0.70-0.91)]. MEDAS-14, RFS and HDI scores were the strongest diet score predictors of severe NAFLD. A healthy diet might protect against NAFLD development irrespective of the specific approach used to assess diet. However, following these score recommendations could represent optimal dietary approaches to mitigate NAFLD risk.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Welsh Assembly Government and the British Heart Foundation
Organisme : National Health and Medical Research Council Emerging Leadership Fellowship
ID : APP1173803
Organisme : Royal Thai Government Scholarship
Organisme : Chilean Government
Informations de copyright
© 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
Teng ML, Ng CH, Huang DQ, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29:S32-s42.
Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851-861.
Le MH, Yeo YH, Li X, et al. 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:2809-2817.
Fabbrini E, Klein SS. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679-689.
Ullah R, Rauf N, Nabi G, et al. Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates. Int J Biol Sci. 2019;15:265-276.
Anania C, Perla FM, Olivero F, Pacifico L, Chiesa C. Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol. 2018;24:2083-2094.
George ES, Forsyth A, Itsiopoulos C, et al. Practical dietary recommendations for the prevention and management of nonalcoholic fatty liver disease in adults. Adv Nutr. 2018;9:30-40.
Zelber-Sagi S, Ivancovsky-Wajcman D, Fliss Isakov N, et al. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J Hepatol. 2018;68:1239-1246.
Rong L, Zou J, Ran W, et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol (Lausanne). 2022;13:1087260.
EASL-EASD-EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388-1402.
Zelber-Sagi S, Oren RV. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol. 2011;17:3377-3389.
Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13:3-9.
Haigh L, Kirk C, El Gendy K, et al. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Clin Nutr. 2022;41:1913-1931.
Ma J, Hennein R, Liu C, et al. Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease. Gastroenterology. 2018;155:107-117.
Videla LA, Hernandez-Rodas MC, Metherel AH, Valenzuela R. Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: impact on non-alcoholic fatty liver disease. Prostaglandins Leukot Essent Fatty Acids. 2022;181:102441.
Khalatbari-Soltani S, Marques-Vidal P, Imamura F, Forouhi NG. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the swiss CoLaus cohort study. BMJ Open. 2020;10:e040959.
Doustmohammadian A, Clark CCT, Maadi M, et al. Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol cohort study (AmolCS). Sci Rep. 2022;12:2131.
Fu J, Shin S. Dietary patterns and risk of non-alcoholic fatty liver disease in Korean adults: a prospective cohort study. BMJ Open. 2023;13:e065198.
Zhang S, Gu Y, Bian S, et al. Dietary patterns and risk of non-alcoholic fatty liver disease in adults: a prospective cohort study. Clin Nutr. 2021;40:5373-5382.
Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;29:101133.
Collins R. What makes UK biobank special? Lancet. 2012;379:1173-1174.
Palmer LJ. UK biobank: bank on it. Lancet. 2007;369:1980-1982.
Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS med. 2015;12:e1001779.
Liu B, Young H, Crowe FL, et al. Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies. Public Health Nutr. 2011;14:1998-2005.
Greenwood DC, Hardie LJ, Frost GS, et al. Validation of the Oxford WebQ online 24-hour dietary questionnaire using biomarkers. Am J Epidemiol. 2019;188:1858-1867.
McCance RA, Widdowson EM. McCance and Widdowson's the Composition of Foods. Royal Society of Chemistry; 2014.
Bradbury KE, Young HJ, Guo W, Key TJ. Dietary assessment in UK biobank: an evaluation of the performance of the touchscreen dietary questionnaire. J Nutr Sci. 2018;7:e6.
Martínez-González MA, Fernández-Jarne E, Serrano-Martínez M, Wright M, Gomez-Gracia E. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur J Clin Nutr. 2004;58:1550-1552.
Papadaki A, Johnson L, Toumpakari Z, et al. Validation of the English version of the 14-item Mediterranean diet adherence screener of the PREDIMED study, in people at high cardiovascular risk in the UK. Nutrients. 2018;10. https://www.mdpi.com/2072-6643/10/2/138
Shannon OM, Ranson JM, Gregory S, et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK biobank prospective cohort study. BMC med. 2023;21:81.
Livingstone KM, Abbott G, Bowe SJ, Ward J, Milte C, McNaughton SA. Diet quality indices, genetic risk and risk of cardiovascular disease and mortality: a longitudinal analysis of 77 004 UK biobank participants. BMJ Open. 2021;11:e045362.
Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015;11:1007-1014.
Golzarand M, Azizi MP. Adherence to the MIND diet and the risk of cardiovascular disease in adults: a cohort study. Food Funct. 2022;13:1651-1658.
Hagström H, Adams LA, Allen AM, et al. Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology. 2021;74:474-482.
Townsend PPM, Beattie A. Health and Deprivation. Inequality and the North. Health Policy; 1988:10.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-237.
Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.
Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC med. 2011;9:48.
Guo W, Bradbury KE, Reeves GK, Key TJ. Physical activity in relation to body size and composition in women in UK biobank. Ann Epidemiol. 2015;25:406-413.e406.
Petermann-Rocha F, Gray SR, Forrest E, et al. Associations of muscle mass and grip strength with severe NAFLD: a prospective study of 333,295 UK biobank participants. J Hepatol. 2022;76:1021-1029.
Govindarajulu US, Malloy EJ, Ganguli B, Spiegelman D, Eisen EA. The comparison of alternative smoothing methods for fitting non-linear exposure-response relationships with cox models in a simulation study. Int J Biostat. 2009;5. https://www.degruyter.com/document/doi/10.2202/1557-4679.1104/html
Ho FK, Cole TJ. Non-linear predictor outcome associations. BMJ Med. 2023;2:e000396.
Della Torre S. Beyond the X factor: relevance of sex hormones in NAFLD pathophysiology. Cell. 2021;10:2502.
Dolce A, Della Torre S. Sex, nutrition, and NAFLD: relevance of environmental pollution. Nutrients. 2023;15:2335.
Skinner RC, Hagaman JA. The interplay of Western diet and binge drinking on the onset, progression, and outlook of liver disease. Nutr Rev. 2021;80:503-512.
Inci MK, Park SH, Helsley RN, Attia SL, Softic S. Fructose impairs fat oxidation: implications for the mechanism of western diet-induced NAFLD. J Nutr Biochem. 2023;114:109224.
Hassani Zadeh S, Mansoori A Hosseinzadeh (2021) Relationship between dietary patterns and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Gastroenterol Hepatol 36, 1470-1478.
Lecoultre V, Egli L, Carrel G, et al. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity. 2013;21:782-785.
Laube H, Klör H, Fussgänger R, et al. The effect of starch, sucrose, glucose and fructose on lipid metabolism in rats. Ann Nutr Metab. 1973;15:273-280.
Coronati M, Baratta F, Pastori D, Ferro D, Angelico F, del Ben M. Added fructose in non-alcoholic fatty liver disease and in metabolic syndrome: a narrative review. Nutrients. 2022;14(6):1127.
The diagnosis and management of nonalcoholic fatty liver disease. Practice guidance from the American Association for the Study of Liver Diseases. Clin Liver Dis (Hoboken). 2018;11(4):81.
Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889-919.
Osadchiy T, Poliakov I, Olivier P, Rowland M, Foster E. Progressive 24-hour recall: usability study of short retention intervals in web-based dietary assessment surveys. J med Internet Res. 2020;22:e13266.
Schneider KM, Schneider CVA. New era for steatotic liver disease: evaluating the novel nomenclature in the UK biobank. J Hepatol. 2023;30:876-881.
Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186:1026-1034.
Batty GD, Gale CR, Kivimäki M, Deary IJ, Bell S. Comparison of risk factor associations in UK biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;368:m131.